These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 21767586)
21. Functional analysis of bioactivated and antiinfective PDLLA - coated surfaces. Haidari S; Boskov M; Schillinger U; Bissinger O; Wolff KD; Plank C; Kolk A J Biomed Mater Res A; 2017 Jun; 105(6):1672-1683. PubMed ID: 28218496 [TBL] [Abstract][Full Text] [Related]
22. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Schmidmaier G; Lucke M; Wildemann B; Haas NP; Raschke M Injury; 2006 May; 37 Suppl 2():S105-12. PubMed ID: 16651063 [TBL] [Abstract][Full Text] [Related]
23. Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Pauly S; Luttosch F; Morawski M; Haas NP; Schmidmaier G; Wildemann B Bone; 2009 Sep; 45(3):505-11. PubMed ID: 19464400 [TBL] [Abstract][Full Text] [Related]
24. Designer Dual Therapy Nanolayered Implant Coatings Eradicate Biofilms and Accelerate Bone Tissue Repair. Min J; Choi KY; Dreaden EC; Padera RF; Braatz RD; Spector M; Hammond PT ACS Nano; 2016 Apr; 10(4):4441-50. PubMed ID: 26923427 [TBL] [Abstract][Full Text] [Related]
25. Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier. Min J; Braatz RD; Hammond PT Biomaterials; 2014 Mar; 35(8):2507-17. PubMed ID: 24388389 [TBL] [Abstract][Full Text] [Related]
26. Depot injectable biodegradable nanoparticles loaded with recombinant human bone morphogenetic protein-2: preparation, characterization, and in vivo evaluation. Hassan AH; Hosny KM; Murshid ZA; Alhadlaq A; Alyamani A; Naguib G Drug Des Devel Ther; 2015; 9():3599-606. PubMed ID: 26203226 [TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration. Wang G; Kucharski C; Lin X; Uludağ H J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316 [TBL] [Abstract][Full Text] [Related]
28. Dual growth factor delivery from biofunctionalized allografts: Sequential VEGF and BMP-2 release to stimulate allograft remodeling. Sharmin F; McDermott C; Lieberman J; Sanjay A; Khan Y J Orthop Res; 2017 May; 35(5):1086-1095. PubMed ID: 27155087 [TBL] [Abstract][Full Text] [Related]
29. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Lind M Acta Orthop Scand Suppl; 1998 Oct; 283():2-37. PubMed ID: 9856074 [TBL] [Abstract][Full Text] [Related]
30. Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration. Yilgor P; Sousa RA; Reis RL; Hasirci N; Hasirci V J Mater Sci Mater Med; 2010 Nov; 21(11):2999-3008. PubMed ID: 20740306 [TBL] [Abstract][Full Text] [Related]
31. Stimulation of bone healing by sustained bone morphogenetic protein 2 (BMP-2) delivery. Faßbender M; Minkwitz S; Strobel C; Schmidmaier G; Wildemann B Int J Mol Sci; 2014 May; 15(5):8539-52. PubMed ID: 24830556 [TBL] [Abstract][Full Text] [Related]
32. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Kempen DH; Lu L; Heijink A; Hefferan TE; Creemers LB; Maran A; Yaszemski MJ; Dhert WJ Biomaterials; 2009 May; 30(14):2816-25. PubMed ID: 19232714 [TBL] [Abstract][Full Text] [Related]
33. Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. Raiche AT; Puleo DA J Biomed Mater Res A; 2004 May; 69(2):342-50. PubMed ID: 15058007 [TBL] [Abstract][Full Text] [Related]
34. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857 [TBL] [Abstract][Full Text] [Related]
35. Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. Gollwitzer H; Ibrahim K; Meyer H; Mittelmeier W; Busch R; Stemberger A J Antimicrob Chemother; 2003 Mar; 51(3):585-91. PubMed ID: 12615858 [TBL] [Abstract][Full Text] [Related]
36. Porous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres. Li Q; Zhou G; Yu X; Wang T; Xi Y; Tang Z Biomed Eng Online; 2015 Apr; 14():33. PubMed ID: 25881175 [TBL] [Abstract][Full Text] [Related]
37. Fosfomycin Addition to Poly(D,L-Lactide) Coating Does Not Affect Prophylaxis Efficacy in Rat Implant-Related Infection Model, But That of Gentamicin Does. Gulcu A; Akman A; Demirkan AF; Yorukoglu AC; Kaleli I; Bir F PLoS One; 2016; 11(11):e0165544. PubMed ID: 27806071 [TBL] [Abstract][Full Text] [Related]
38. In vitro effects of combined and sequential delivery of two bone growth factors. Raiche AT; Puleo DA Biomaterials; 2004 Feb; 25(4):677-85. PubMed ID: 14607506 [TBL] [Abstract][Full Text] [Related]
39. Efficient bone regeneration induced by bone morphogenetic protein-2 released from apatite-coated collagen scaffolds. Yang HS; La WG; Park J; Kim CS; Im GI; Kim BS J Biomater Sci Polym Ed; 2012; 23(13):1659-71. PubMed ID: 21888760 [TBL] [Abstract][Full Text] [Related]
40. Local gentamicin delivery from resorbable viscous hydrogels is therapeutically effective. Overstreet D; McLaren A; Calara F; Vernon B; McLemore R Clin Orthop Relat Res; 2015 Jan; 473(1):337-47. PubMed ID: 25227556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]